Vivos Inc (RDGL)

[Musical Shares]

It's junk science.

The FDA doesn't actually "approve" animal products. And the less stringent "evaluation" (if we can actually call it that) doesn't match on any level to FDA approval for human use.

The problem starts with the fact that IsoPet is seen on here as "a product that works." And that might be true. But it's a thinly veiled assertion.

IsoPet "works" because taking a radioactive element to tissue will, without a doubt, destroy it. So, in essence, it "works." But that's not real science. There are numerous problems with that assertion.

A. We know next to nothing about the actual genotoxicity or dosage reports of these animals.
B. There underlining ailment is different than what is being treated for humans (soft tissue sarcomas vs papillary thyroid).
C. The production, shipment, and storage of this medical device are unknown. And in the world of radioactive isotopes that's a big deal.

As for the India study, it's just another avenue to string "shareholders" along.

They claimed they went to India to get "more data." You don't need human data for pre-clinical studies. It's why it's called pre-clinical.